The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price decrease of -58.04%. However, over the past six months, we’ve seen a stronger performance of -37.52%. The price of TXG fallen by 4.17% over the last 30 days. And in the last five days, it has surged by 4.12%.
10x Genomics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $57.90 on 12/20/23, and the lowest price during that time was $15.28, recorded on 07/10/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of TXG Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. 10x Genomics Inc’s current trading price is -59.45% away from its 52-week high, while its distance from the 52-week low is 53.66%. The stock’s price range over this timeframe has been between $15.28 and $57.90. The shares of the Healthcare sector company recorded a trading volume of approximately 1.88 million for the day, which was comparatively higher than the average daily volume of 1.84 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
10x Genomics Inc (TXG) has experienced a quarterly rise of 17.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.83B and boasts a workforce of 1259 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.68, with a change in price of -4.11. Similarly, 10x Genomics Inc recorded 1,755,890 in trading volume during the last 100 days, posting a change of -14.90%.
TXG’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TXG stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
TXG Stock Stochastic Average
10x Genomics Inc’s raw stochastic average for the past 50 days is currently at 85.45%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 66.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 36.21% and 25.65%, respectively.
